Welcome : Guest

CSL Ltd. (Australia) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about CSL Ltd., which is principally involved in Biotherapeutics Business. Illustrated with 97 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-63472
Price: $3500
Company Type: Public
Pages: 114
Date: February 2017
Market Data Tables: 97

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: CSL Ltd.'s Sales by Product Segment Worldwide (2016) in Percentage for Immunoglobulins, Haemophilia, Albumin, Specialty, and Seqirus......18
Table 2: CSL Ltd.'s Sales by Business Segment Worldwide (2015-2016) in Percentage for CSL Behring, Seqirus, and Others......19
Table 3: CSL Ltd.'s Sales by Geographic Region Worldwide (2016) in Percentage for North America, Europe, Australia, Asia, and Others......20
Table 4: CSL Ltd.’s Sales by Product Segment Worldwide (2014-2015) in Percentage for Immunoglobulins, Plasma-Derived Coagulants, Helixate, Albumin, and Others......21
Table 5: CSL Ltd.’s Sales by Business Segment Worldwide (2014-2015) in Percentage for CSL Behring, BioCSL, and Other Revenue......22
Table 6: CSL Ltd.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for North America, Europe, Australia, Asia, and Others......23
Table 7: CSL Ltd.’s (Operations) Sales by Geographic Region Worldwide (2013-2014) in Percentage for Australia, United States, Germany and Rest of World......24
Table 8: CSL Ltd.’s Sales by Product Segment Worldwide (2014) in Percentage for Immunoglobulins, Plasma-Derived Coagulants, Helixate, Albumin and Others......25
Diagnostic Testing......26
Table 9: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......26
Table 10: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......27
Table 11: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......28
Table 12: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......29
Table 13: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......30
Table 14: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......31
Table 15: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......32
Table 16: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......33
Vaccines......34
Table 17: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......34
Pharmaceuticals......35
Table 18: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......35
Table 19: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......36
Table 20: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......37
Table 21: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......38
Table 22: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......39
Table 23: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......40
Table 24: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......41
Table 25: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......42
Table 26: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......43
Table 27: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......44
Table 28: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......45
Table 29: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......46
Table 30: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......47
Table 31: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......48
Table 32: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......49
Table 33: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......50
Table 34: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......51
Table 35: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......52
Table 36: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......53
Table 37: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......54
Table 38: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......55
Table 39: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......56
Table 40: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......57
Table 41: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......58
Table 42: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......59
Table 43: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......60
Immunotherapy......61
Table 44: Immunotherapy Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Subcutaneous, and Sublingual......61
Table 45: Immunotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union, United States and Rest of the World......62
Table 46: No. of Patients for Immunotherapy by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Europe, North America, and Others......63
Table 47: No. of Patients for Immunotherapy by Age Group in the US (2015) - Percentage Market Share Breakdown by Value for 0-4 Patient Pool, 10 - 14 Patient Pool, 15 - 19 Patient Pool, 5-9 Patient Pool, Adult Patient Pool (over 65), and Adult Patient Pool (under 65)......64
Intravenous immunoglobulin (IVIG)......65
Table 48: Intravenous Immunoglobulin (IVIG) Market by Region Worldwide (2015) - Percentage Market Share Breakdown by Volume Sales for Australia, Canada, Europe (East & West) and New Zealand, US, Others (Excluding US (Including Japan))......65
Table 49: Intravenous Immunoglobulin (IVIG) Usage by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Hematology and Oncology, Immune Thrombocytopenic Purpura (ITP), Neurology, Pelvic Inflammatory Disease (PID), and Others......66
Table 50: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume Sales, for Europe, US, and Others......67
Table 51: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales, for Europe, US, and Others......68
Table 52: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2015) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......69
Alpha 1-antitrypsin (AAT)......70
Table 53: Alpha 1-antitrypsin (AAT) Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Aralast NP, Glassia IV, Prolastin Prolastin C, and Zemaira......70
Hemophilia Treatment......71
Table 54: Hemophilia Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hemophilia A, Hemophilia B, Inhibitor, and Von Willebrand Disease......71
Plasma Proteins......72
Table 55: Plasma Proteins Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Africa, Asia-Pacific, Europe, Middle East, North America, Oceania, and South America......72
Table 56: Plasma Proteins Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Globulins and Others......73
Diagnostic Testing......74
Table 57: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......74
Vaccines......75
Table 58: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......75
Diphtheria and Tetanus Vaccines......76
Table 59: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......76
Hepatitis A Vaccines......77
Table 60: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......77
Hepatitis B (Recombinant) Vaccines......78
Table 61: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......78
Hepatitis A and Typhoid Polysaccharide Vaccines......79
Table 62: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......79
Human Papillomavirus Vaccines......80
Table 63: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......80
Human Rotavirus Vaccines......81
Table 64: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......81
Influenza Vaccines......82
Table 65: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......82
Measles, Mumps and Rubella Vaccines......83
Table 66: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......83
Tetanus Toxoid, reduced Diphthera Vaccines......84
Table 67: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......84
Typhoid Vaccines......85
Table 68: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......85
Varilrix Vaccines......86
Table 69: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......86
Pharmaceuticals......87
Table 70: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......87
Table 71: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Others......88
Table 72: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......89
Table 73: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......90
Table 74: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......91
Table 75: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......92
Preclinical Pharmaceuticals......93
Table 76: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......93
Prescription Pharmaceuticals......94
Table 77: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......94
Table 78: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......95
Table 79: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......96
Table 80: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......97
Table 81: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......98
RadioPharmaceuticals......99
Table 82: Market Shares of Leading Radiopharmaceutical Drug Providers in the US (2015) - Percentage Breakdown by Value for Amersham Plc, Cardinal Health, Inc., Independents, and Triad Healthcare Inc.......99
Human Albumin......100
Table 83: Market Shares of Leading Human Albumin Companies in China (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Chengdu Institute of Biological Products Co., Ltd., China Biologic Products, Inc., CSL Behring, Grifols, S.A., and Others......100
Table 84: Market Shares of Leading Human Albumin Manufacturers in China (2015) - Percentage Breakdown by Value for Baxter International, Inc., Chengdu Institute of Biological Products Co., Ltd., China Biologic Products, Inc., CSL Behring LLC, Grifols S.A. and Others......101
Intravenous immunoglobulin (IVIG)......102
Table 85: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A., Octapharma AG and Others......102
Table 86: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Therapy Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Biotest AG, CSL Limited, Grifols, S.A., Talecris Biotherapeutics, Inc., Kedrion S.p.A., Octapharma AG, and Others......103
Table 87: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Producers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A, LFB Group, Octapharma AG, and Others......104
Table 88: Market Shares of Leading Intravenous immunoglobulin (IVIG) Manufacturers in China (2015) - Percentage Breakdown by Value for Chengdu Institute of Biological Products Co., Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanghai Institute of Biological Products Co., Ltd., Shanxi Kangbao Biological Product Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. and Others......105
Table 89: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in Europe (2015) - Percentage Breakdown by Value for Baxter International Inc., Biotest AG, CSL Ltd., Grifols, S.A (Incl.Talecris), Octapharma AG, and Others......106
Table 90: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Ltd., Grifols, S.A (Incl.Talecris), and Others......107
Alpha 1-antitrypsin (AAT)......108
Table 91: Market Shares of Leading Alpha 1-Antitrypsin (AAT) Producers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., CSL Ltd., Grifols, S.A., and Others......108
Hemophilia Treatment......109
Table 92: Market Shares of Leading Hemophilia Treatment Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Baxter International, Inc., Bayer AG, CSL Ltd. Novo Nordisk, Pfizer, Inc., and Others......109
Plasma Proteins......110
Table 93: Market Shares of Leading Plasma Protein Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL Ltd., Grifols, S.A., Octapharma AG, and Others......110
Table 94: Market Shares of Leading Plasma Protein Product Producers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A, LFB Group, Octapharma AG, Shire Plc, and Others......111
Table 95: Market Shares of Leading Plasma Protein Product Producers in the US (2015) - Percentage Breakdown by Volume for Baxter International, Inc., CSL Ltd., Grifols, S.A., and Others......112
Table 96: CSL Ltd.’s Sales by Geographic Region Worldwide (2014) in Percentage for North America, Europe, Australia, Asia and Others......113
Table 97: CSL Ltd.’s Sales by Business Segment Worldwide (2013-2014) in Percentage for CSL Behring, BioCSL and Other Revenue......114